Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Ketoprofen through Inhibition of RNA Binding Protein PUM1

Clinical trials of new drugs often face a high failure rate of approximately 45 percent due to safety and toxicity concerns. Repurposing drugs with well-established safety profiles becomes crucial in addressing this challenge. Colon cancer ranks as the third most prevalent cancer and the second lead...

Full description

Bibliographic Details
Main Authors: Ravi Gor, Ali Gharib, Priya Dharshini Balaji, Thirumurthy Madhavan, Satish Ramalingam
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Toxics
Subjects:
Online Access:https://www.mdpi.com/2305-6304/11/8/669